You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: The ACUITY Timing Trial
Gregg W. Stone; Michel E. Bertrand; Jeffrey W. Moses; E. Magnus Ohman; A. Michael Lincoff; James H. Ware; Stuart J. Pocock; Brent T. McLaurin; David A. Cox; M. Zubair Jafar; Harish Chandna; Franz Hartmann; Franz Leisch; Ruth H. Strasser; Martin Desaga; Thomas D. Stuckey; Richard B. Zelman; Ira H. Lieber; David J. Cohen; Roxana Mehran; Harvey D. White; for the ACUITY Investigators
JAMA 2007; 297: 591-602.
[Abstract][Full text][PDF]
Original Contributions Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery
Dennis T. Mangano; Yinghui Miao; Alain Vuylsteke; Iulia C. Tudor; Rajiv Juneja; Daniela Filipescu; Andreas Hoeft; Manuel L. Fontes; Zak Hillel; Elisabeth Ott; Tatiana Titov; Cynthia Dietzel; Jack Levin; for the Investigators of The Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation
JAMA 2007; 297: 471-479.
[Abstract][Full text][PDF][ JAMA News Video ]
Original Contributions Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
Eric L. Eisenstein; Kevin J. Anstrom; David F. Kong; Linda K. Shaw; Robert H. Tuttle; Daniel B. Mark; Judith M. Kramer; Robert A. Harrington; David B. Matchar; David E. Kandzari; Eric D. Peterson; Kevin A. Schulman; Robert M. Califf
JAMA 2007; 297: 159-168.
[Abstract][Full text][PDF]
Lab, Field, & Clinic Healing Power Found in "Nano Knitting"
Original Contributions Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial
